spastic cerebral palsy. Cerebral palsy
Conditions
Interventions
In this study, the effectiveness of drug therapy in cerebral palsy patients who were included in the study according to the inclusion and exclusion criteria will be examined according to the following
After giving the above drugs to each of the patients with the specified dosage in the first three visits, 3 and 6 months later, the patients are examined with examination and radiology and the results
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with spastic cerebral palsy with or without a history of previous drug treatment without a history of surgery within the past year
Exclusion criteria
Exclusion criteria: Patients who have not returned for a follow-up visit during this period Patients who have had surgery within the past year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Spasticity. Timepoint: The beginning of the study, 3 and 6 months later. Method of measurement: Ashworth scale.;Range of motion. Timepoint: The beginning of the study, 3 and 6 months later. Method of measurement: Goniometer.;Drug side effect. Timepoint: The beginning of the study, 3 and 6 months later. Method of measurement: Medication side effects questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Amin Choobdar
Tehran University of Medical Sciences
Outcome results
None listed